Target intelligence / Profile preview

Hemagglutinin protein (H5 subtype)

Molecular classification
Viral envelope glycoprotein, Hemagglutinin, Receptor
01

Overview

Hemagglutinin (HA) is a surface glycoprotein found on influenza viruses, including the H5 subtype. It plays a critical role in viral entry by mediating both receptor binding and membrane fusion. The H5 subtype is most notably associated with highly pathogenic avian influenza A(H5N1), which can infect birds and, less frequently, humans. HA exists as a trimeric spike on the viral envelope, with each spike composed of three identical subunits: HA1 (receptor binding) and HA2 (fusion peptide). Avian-adapted H5 typically prefers α-2,3-linked sialic acids; however, single amino acid mutations (notably at residue 226) can shift specificity toward human-type α-2,6-linked receptors—facilitating cross-species transmission. After endocytosis into host cells, acidic pH triggers conformational changes in HA that drive fusion between viral and endosomal membranes. The high pathogenicity of certain H5 strains (notably HPAI-H5N1) is linked to their ability to be efficiently cleaved/activated by host proteases, and mutations enabling efficient binding to human-type receptors are key determinants for zoonotic potential and pandemic risk.

Other names
H5 hemagglutininHA (H5)H5N1 hemagglutinin
02

Mechanism of action

Target of neutralizing antibodies; target of entry inhibitors (theoretical)

03

Biological functions

Receptor recognition/bindingMembrane fusionViral entry
04

Disease associations

InfectionInfluenzaAvian influenza (H5N1)
05

Safety considerations

Potential for antigenic drift and shift leading to vaccine evasionZoonotic potentialHigh pathogenicity in some strains

Beyond the preview

Go deeper on Hemagglutinin protein (H5 subtype).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein (H5 subtype).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call